VEEV
US EQUITY
Health Care
Health Care Technology
CIK: 1393052
Veeva Systems (VEEV) Quant Factor Diagnostic & Fair Value Model
Veeva Systems (Ticker: VEEV) is listed in the Health Care sector (Health Care Technology). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$323.04
+0.15%
Latest Close (2026-10-23)
Market Cap: $52.30B
P/E Ratio: 48.6
Momentum Strength
3M / 12M
+66.12%
1M: +17.54%
12M: +11.42%
Quality (ROE)
Point-in-Time
+14.72%
Trailing Return on Equity
Technical Trend
RSI 14
85.3
SMA50: $276.93
SMA200: $207.17
Valuation Multiplier
Trailing
48.6
Premium Multiple (> 30x P/E)
📊
Valuation & Multi-Factor Diagnostic
Premium Multiple (> 30x P/E)
VEEV trades at 48.6x P/E, reflecting market-implied growth expectations for forward revenue and cash flow.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线多头 (MA20/50)
Piotroski F-Score: 6/9 (Moderate Financial Health)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 1393052 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-07-31 | 2026-08-27 | - | $273.43M | $1.37B | $1.66 |
| 10-Q | 2026-01-31 | 2026-08-27 | - | - | - | - |
| 10-Q | 2025-07-31 | 2026-08-27 | - | $200.31M | $1.12B | $1.19 |
| 10-Q | 2026-04-30 | 2026-06-05 | - | $260.94M | $1.13B | $1.57 |
| 10-Q | 2025-04-30 | 2026-06-05 | - | $228.19M | $877.16M | $1.37 |
| 10-K | 2026-01-31 | 2026-03-20 | - | $908.91M | $1.42B | $5.44 |
| 10-K | 2025-01-31 | 2026-03-20 | - | $714.14M | $1.09B | $4.32 |
| 10-K | 2024-01-31 | 2026-03-20 | - | $525.71M | $911.34M | $3.22 |
💡 Methodology & Frequently Asked Questions
Key reference details regarding Veeva Systems (VEEV) valuation multiples, momentum factors, and point-in-time filing conventions.
How should VEEV's current valuation multiple be interpreted? ↓
VEEV trades at a trailing P/E of 48.6x within the Health Care sector (premium multiple (> 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are VEEV's key momentum and technical factor indicators? ↓
As of the latest close, VEEV shows a 1-month return of +17.54%, 3-month return of +66.12%, and 12-month return of +11.42%, with a 14-day RSI of 85.3. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for VEEV? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can VEEV be incorporated into systematic factor models? ↓
VEEV can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.